D Ioannides
Overview
Explore the profile of D Ioannides including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
1594
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rudnicka L, Arenbergerova M, Grimalt R, Ioannides D, Katoulis A, Lazaridou E, et al.
J Eur Acad Dermatol Venereol
. 2024 Jan;
38(4):687-694.
PMID: 38169088
Alopecia areata is an autoimmune form of non-scarring hair loss. It is usually characterized by limited areas of hair loss. However, the disease may progress to complete scalp and body...
2.
Bakirtzi K, Sotiriou E, Papadimitriou I, Vakirlis E, Delli F, Ioannides D
J Eur Acad Dermatol Venereol
. 2023 Jan;
37(6):e749-e751.
PMID: 36688248
No abstract available.
3.
Sotiriou E, Bakirtzi K, Papadimitriou I, Tsentemeidou A, Kougkas N, Panagopoulou A, et al.
J Eur Acad Dermatol Venereol
. 2022 Jun;
36(11):e952-e953.
PMID: 35770467
No abstract available.
4.
Borradori L, van Beek N, Feliciani C, Tedbirt B, Antiga E, Bergman R, et al.
J Eur Acad Dermatol Venereol
. 2022 Jun;
36(10):1689-1704.
PMID: 35766904
Background: Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized...
5.
Augustin M, Sator P, von Kiedrowski R, Conrad C, Rigopoulos D, Romanelli M, et al.
J Eur Acad Dermatol Venereol
. 2022 Jun;
36(10):1796-1804.
PMID: 35696305
Background: Randomized controlled trials of secukinumab have shown sustained efficacy and a favourable safety profile in multiple manifestations of psoriatic disease. Objectives: To assess the long-term, real-world retention, effectiveness and...
6.
Ioannides D, Antonakopoulos N, Chasapi V, Oikonomou C, Tampouratzi E, Lazaridou E, et al.
J Eur Acad Dermatol Venereol
. 2022 Apr;
36(11):2055-2063.
PMID: 35451115
Background: Real-world data in patients with moderate psoriasis treated with apremilast is limited. Objectives: To evaluate the effectiveness and safety of apremilast in bio-naïve patients with moderate psoriasis in real-world...
7.
Spyridis I, Papageorgiou C, Apalla Z, Manoli S, Eftychidoy P, Gkentsidi T, et al.
J Eur Acad Dermatol Venereol
. 2022 Apr;
36(9):1564-1567.
PMID: 35426175
Background: Melanomas developing on anatomic sites other than the trunk and extremities have a special pathogenetic and mutational profile, morphologic characteristics and biologic behaviour. Objective: By retrospectively screening the databases...
8.
Sotiriou E, Bakirtzi K, Vakirlis E, Papadimitriou I, Eftychidou P, Trifona M, et al.
J Eur Acad Dermatol Venereol
. 2022 Mar;
36(8):e626-e627.
PMID: 35305054
No abstract available.
9.
Sotiriou E, Bakirtzi K, Papadimitriou I, Tsentemeidou A, Eftychidou P, Eleftheriadis V, et al.
J Eur Acad Dermatol Venereol
. 2021 Dec;
36(5):e359-e361.
PMID: 34923693
No abstract available.
10.
Lallas A, Martinez G, Arceu M, Kyrgidis A, Liopyris K, Brancaccio G, et al.
J Eur Acad Dermatol Venereol
. 2021 Nov;
36(2):222-227.
PMID: 34743367
Background: Squamous cell carcinoma of the lip accounts for 20% of all oral carcinomas. Its diagnosis may be challenging because it clinically resembles actinic cheilitis and inflammatory lesions of the...